Overcoming mitomycin C resistance with semisynthetic derivatives.
D000818:Animals; D001711:Biotransformation; D002277:Carcinoma / Q000188:drug therapy*; D002460:Cell Line; D003110:Colonic Neoplasms / Q000188:drug therapy*; D004247:DNA / Q000378:metabolism; D004351:Drug Resistance; D006801:Humans; D051379:Mice; D016685:Mitomycin; D008937:Mitomycins / Q000378:metabolism / Q000494:pharmacology*; D009368:Neoplasm Transplantation; D013329:Structure-Activity Relationship; D014183:Transplantation, Heterologous
D008937:Mitomycins; D016685:Mitomycin; C046941:N(6)-((dimethylamino)methylene)mitomycin C; D004247:DNA